Bruce Brockstein to Hemangioendothelioma, Epithelioid
This is a "connection" page, showing publications Bruce Brockstein has written about Hemangioendothelioma, Epithelioid.
Connection Strength
0.106
-
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013 Jan; 24(1):257-63.
Score: 0.106